NO179172C - Nytt arylpiperidin-derivat og farmasöytiske blandinger som inneholder det - Google Patents

Nytt arylpiperidin-derivat og farmasöytiske blandinger som inneholder det

Info

Publication number
NO179172C
NO179172C NO931420A NO931420A NO179172C NO 179172 C NO179172 C NO 179172C NO 931420 A NO931420 A NO 931420A NO 931420 A NO931420 A NO 931420A NO 179172 C NO179172 C NO 179172C
Authority
NO
Norway
Prior art keywords
new
pharmaceutical compositions
compositions containing
arylpiperidine derivative
arylpiperidine
Prior art date
Application number
NO931420A
Other languages
English (en)
Norwegian (no)
Other versions
NO931420L (no
NO179172B (no
NO931420D0 (no
Inventor
Marco Baroni
Umberto Guzzi
Michele Arnone
Philippe Soubrie
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Publication of NO931420D0 publication Critical patent/NO931420D0/no
Publication of NO931420L publication Critical patent/NO931420L/no
Publication of NO179172B publication Critical patent/NO179172B/no
Publication of NO179172C publication Critical patent/NO179172C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO931420A 1992-04-17 1993-04-16 Nytt arylpiperidin-derivat og farmasöytiske blandinger som inneholder det NO179172C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9204821A FR2690158B1 (fr) 1992-04-17 1992-04-17 Nouveau derive arylpiperidinique, procede pour sa preparation et compositions pharmaceutiques le contenant.

Publications (4)

Publication Number Publication Date
NO931420D0 NO931420D0 (no) 1993-04-16
NO931420L NO931420L (no) 1993-10-18
NO179172B NO179172B (no) 1996-05-13
NO179172C true NO179172C (no) 1996-08-21

Family

ID=9429039

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931420A NO179172C (no) 1992-04-17 1993-04-16 Nytt arylpiperidin-derivat og farmasöytiske blandinger som inneholder det

Country Status (10)

Country Link
US (1) US5286734A (es)
EP (1) EP0566484A1 (es)
JP (1) JPH0625166A (es)
KR (1) KR930021617A (es)
AU (1) AU661387B2 (es)
CA (1) CA2094164A1 (es)
FR (1) FR2690158B1 (es)
HU (2) HUT70181A (es)
MX (1) MX9302210A (es)
NO (1) NO179172C (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2681931C2 (ru) * 2017-08-01 2019-03-14 Фарид Шамилевич Шагиахметов Фармацевтическая комбинация для лечения алкогольной зависимости

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) * 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
PH17019A (en) * 1980-03-01 1984-05-11 Wyeth John & Brother Ltd 4-piperidyl-or dehydropiperidyl-urea derivatives and method of use
GB2083476B (en) * 1980-09-12 1984-02-08 Wyeth John & Brother Ltd Heterocyclic compounds
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
US4921863A (en) * 1988-02-17 1990-05-01 Eisai Co., Ltd. Cyclic amine derivatives
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
US5153206A (en) * 1988-12-02 1992-10-06 Pfizer Inc. Arylpiperidine derivatives
FR2650505B1 (fr) * 1989-08-07 1994-06-03 Midy Spa Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
AU3695393A (en) 1993-10-21
JPH0625166A (ja) 1994-02-01
FR2690158A1 (fr) 1993-10-22
HU211842A9 (en) 1995-12-28
MX9302210A (es) 1993-10-01
HUT70181A (en) 1995-09-28
NO931420L (no) 1993-10-18
EP0566484A1 (fr) 1993-10-20
NO179172B (no) 1996-05-13
NO931420D0 (no) 1993-04-16
HU9301115D0 (en) 1993-07-28
US5286734A (en) 1994-02-15
FR2690158B1 (fr) 1994-07-22
KR930021617A (ko) 1993-11-22
AU661387B2 (en) 1995-07-20
CA2094164A1 (en) 1993-10-18

Similar Documents

Publication Publication Date Title
PT589843E (pt) Composicoes farmaceuticas contendo ciclosporinas
BR1100329A (pt) Composto e formulação farmacêutica
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
BR1100824A (pt) Composto e composição farmacêutica
FI955144A0 (fi) Päällystetyt farmaseuttiset koostumukset
CY2005007I1 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
NO955034D0 (no) Nye substituerte 1H-imidazoler og farmasöytiske preparater inneholdende disse
NO975985D0 (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
BR9500784A (pt) Composto e formulação farmacêutica
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
FI944832A (fi) Farmaseuttinen koostumus
NO976128L (no) Forbindelser og farmasöytiske blandinger som inneholder dem
NO975984D0 (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
BR9200058A (pt) Composto e composicao farmaceutica
ITMI932540A0 (it) Composizione farmaceutica
NO304890B1 (no) Farmas°ytiske forbindelser og farmas°ytiske preparater
NO306114B1 (no) Substituerte 4-fenyltiazolderivater og farmasöytiske blandinger som inneholder dem
EE9900206A (et) N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
DK0508334T3 (da) Aminophenolderivater og farmaceutiske præparater indeholdende disse
ITMI932014A0 (it) Composizioni farmaceutiche orali effervescenti contenenti estrone
NO308004B1 (no) Nye aminofenylfosfonsyreforbindelser og farmasøytiske sammensetninger inneholdende dem
LV10579A (lv) Farmaceitiska kompozicija
NO179172C (no) Nytt arylpiperidin-derivat og farmasöytiske blandinger som inneholder det
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
NO178066C (no) Substituert sulfonamidderivat og farmasöytisk formulering inneholdende det samme